Description:Torin1 is a small molecule inhibitor primarily known for its role in targeting the mechanistic target of rapamycin (mTOR), a crucial regulator of cell growth, proliferation, and survival. It is characterized by its ability to selectively inhibit both mTORC1 and mTORC2 complexes, making it a valuable tool in research related to cancer, metabolic disorders, and aging. Torin1 is often utilized in studies investigating the pathways of autophagy and cellular metabolism, as it can induce autophagy under certain conditions. The compound is typically administered in a laboratory setting and is soluble in organic solvents, which facilitates its use in various biochemical assays. Its effectiveness and specificity make it a significant compound in pharmacological research, particularly in the development of therapeutic strategies targeting mTOR signaling pathways. However, like many experimental drugs, its safety and efficacy in clinical settings require further investigation.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.
